Aims and Scope of Current Pharmaceutical Design
Current Pharmaceutical Design is a peer-reviewed medical journal which covers issues related to pharmacology and medicinal chemistry. Each issue is devoted to a single major therapeutic area. For each issue, an executive editor is chosen who is an acknowledged authority in that field. Less
Key Metrics
CiteScore 

5.8
H-Index 

176
Impact Factor 

< 5
SJR 

Q2Pharmacology

SNIP 

0.73
Recommended pre-submission checks
Powered by 

Topics Covered on Current Pharmaceutical Design
Current Pharmaceutical Design Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Weekly |
| General Details | |
| Language | English |
| Frequency | Weekly |
| Publication Start Year | 1995 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Pharmaceutical Design ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Current Pharmaceutical Design
Nanostructured Lipid Carriers in Drug Targeting: Characterization, Patents, and Recent Innovations.
- 30 Jun 2026
- Current pharmaceutical design
Cross-Tissue Transcriptome-Wide Association Study Prioritizes Candidate Genes and Compound-Associated Signatures for Osteoarthritis.
- 30 Jun 2026
- Current pharmaceutical design
Overcoming Physiological Barriers in Brain Tumor Therapy: Advances in Nanomedicine, Ultramolecular Pharmaceuticals, and Targeted Drug Delivery.
- 30 Jun 2026
- Current pharmaceutical design
Emerging Role of AI in Gastroenterology and Hepatology: Revolutionizing Medical Device-Assisted Diagnosis.
- 30 Jun 2026
- Current pharmaceutical design
Breathing Life into Research: The Transformative Potential of Lung-on-a-Chip Technology.
- 30 Jun 2026
- Current pharmaceutical design
Combining Network Pharmacology, Machine Learning, Molecular Docking, and Experimental Validation to Explore the Mechanism of Danggui-Shaoyao-San in treating Rheumatoid arthritis.
- 23 Jun 2026
- Current pharmaceutical design
Nanostructured Lipid Carriers in Drug Targeting: Characterization, Patents, and Recent Innovations.
- 30 Jun 2026
- Current pharmaceutical design
Cross-Tissue Transcriptome-Wide Association Study Prioritizes Candidate Genes and Compound-Associated Signatures for Osteoarthritis.
- 30 Jun 2026
- Current pharmaceutical design
Overcoming Physiological Barriers in Brain Tumor Therapy: Advances in Nanomedicine, Ultramolecular Pharmaceuticals, and Targeted Drug Delivery.
- 30 Jun 2026
- Current pharmaceutical design
Emerging Role of AI in Gastroenterology and Hepatology: Revolutionizing Medical Device-Assisted Diagnosis.
- 30 Jun 2026
- Current pharmaceutical design
Breathing Life into Research: The Transformative Potential of Lung-on-a-Chip Technology.
- 30 Jun 2026
- Current pharmaceutical design
Combining Network Pharmacology, Machine Learning, Molecular Docking, and Experimental Validation to Explore the Mechanism of Danggui-Shaoyao-San in treating Rheumatoid arthritis.
- 23 Jun 2026
- Current pharmaceutical design